✦ LIBER ✦
Quantitative analyses reveal substantial differences between Ofatumumab (OFA) and Rituximab (RTX) in mediating Complement-Dependent Cytotoxicity (CDC) of B cell lines and Chronic Lymphocytic Leukemia (CLL) cells
✍ Scribed by P. Taylor
- Book ID
- 113805544
- Publisher
- Elsevier Science
- Year
- 2011
- Tongue
- English
- Weight
- 81 KB
- Volume
- 48
- Category
- Article
- ISSN
- 0161-5890
No coin nor oath required. For personal study only.